虚血性発作治療のグローバル臨床試験動向（2014年H2）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Ischemic Stroke 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Ischemic Stroke to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Ischemic Stroke to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Ischemic Stroke 25
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Ischemic Stroke Therapeutics Clinical Trials 33
Prominent Drugs 35
Latest Clinical Trials News on Ischemic Stroke 36
Jun 27, 2014: Lundbeck provides update on the development program for desmoteplase 36
May 05, 2014: Cytomedix Announces Results of RECOVER-Stroke Phase 2 Study 36
Clinical Trial Profiles 38
Clinical Trial Overview of Top Companies 38
Eli Lilly and Company 38
Clinical Trial Overview of Eli Lilly and Company 38
Daiichi Sankyo Company, Limited 39
Clinical Trial Overview of Daiichi Sankyo Company, Limited 39
Sanofi 40
Clinical Trial Overview of Sanofi 40
H. Lundbeck A/S 41
Clinical Trial Overview of H. Lundbeck A/S 41
C. H. Boehringer Sohn AG & Co. KG 42
Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG 42
AstraZeneca PLC 43
Clinical Trial Overview of AstraZeneca PLC 43
Pfizer Inc. 44
Clinical Trial Overview of Pfizer Inc. 44
D-Pharm Ltd. 45
Clinical Trial Overview of D-Pharm Ltd. 45
Mitsubishi Chemical Holdings Corporation 46
Clinical Trial Overview of Mitsubishi Chemical Holdings Corporation 46
Bayer AG 47
Clinical Trial Overview of Bayer AG 47
Clinical Trial Overview of Top Institutes / Government 48
Seoul National University Hospital 48
Clinical Trial Overview of Seoul National University Hospital 48
China Academy of Chinese Medical Sciences 50
Clinical Trial Overview of China Academy of Chinese Medical Sciences 50
National Institute of Neurological Disorders and Stroke 51
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 51
Xijing Hospital 52
Clinical Trial Overview of Xijing Hospital 52
University of Texas Health Science Center at Houston 53
Clinical Trial Overview of University of Texas Health Science Center at Houston 53
Hallym University Medical Center 54
Clinical Trial Overview of Hallym University Medical Center 54
Erasmus MC 55
Clinical Trial Overview of Erasmus MC 55
Charite – Universitatsmedizin Berlin 56
Clinical Trial Overview of Charite – Universitatsmedizin Berlin 56
University of Cincinnati 57
Clinical Trial Overview of University of Cincinnati 57
University of California, San Diego 58
Clinical Trial Overview of University of California, San Diego 58
Five Key Clinical Profiles 59
Appendix 80
Abbreviations 80
Definitions 80
Research Methodology 81
Secondary Research 81
About GlobalData 82
Contact Us 82
Disclaimer 82
Source 82